Context: Abuse of the drug, Phensedyl like any other drug might exert adverse effects on vital organs of the human body like liver, kidney and heart.
Introduction
Drug addiction is a life threatening challenge to the public health. The drug addicts are prone to develop chronic killer diseases like AIDs, cancers, cardiovascular diseases, kidney dysfunction (UNDCP 1997 , Varela et al. 1997 , WHO 1992 , Battjes et al. 1989 , Harris and Garret 1972 . In Bangladesh, majority of drug addicts are claimed to be suffering from infectious diseases like tuberculosis, hepatitis, respiratory infections, contagious skin diseases (CTC 2000) and STDs and some of them are also inflicted with HIV infection (ICDDR'B 1999) . The abuse (drinking) of an antitussive, Phensedyl syrup has been reported in several countries in South Asia. In India, it is reportedly being used as a cheap substitute for drugs or alcohol. In Nepal, to prevent such abuse, the sale of Phensedyl and other codeine-based cough syrups has been prohibited. Increasing abuse of Phensedyl was reported in Bangladesh. The abuse of Phensedyl in Bangladesh is extremely high possibly because of its easy availability and comparatively lower price. Phensedyl, once available only in 250 ml medicine bottles that were smuggled into Bangladesh out of India, can now be found in large barrels. The codeine phosphate content of some Phensedyl batches found on the illicit markets in Bangladesh and Nepal is much higher than that of the Phensedyl that is licitly available in India (Release of INCB Report for 1995 Regional Update: South Asia).
According to the Government of Bangladesh, Phensedyl has become the main drug of abuse among young people in some areas of the country, including Dhaka. Illicit traffic in and abuse of Phensedyl and other similar cough syrups have created problems in some south-east Asian countries as well (for example Myanmar (Release of INCB Report for 1995 Regional Update: South Asia).
Any drug when abused may exert adverse effects on vital organs of the human body resulting in different degrees of damages to organs like liver, kidney, heart and others. Abuse of the drug Phensedyl, like any other drugs might be associated in development of health problems, different pathophysiological states i.e. various types of diseases. Following the biochemical changes after drug intake may be useful in such assessments.
Although researches on drug addiction and drug abuse have been carried out globally and as well as in Bangladesh, as far as our knowledge goes; no biochemical study appears to be having been done so far in Bangladesh and else where on Phensedyl abuse. The illicit and increasing abuse of the drug Phensedyl in Bangladesh may be associated in developing health problems. To establish the fact, in the present study, several important parameters of biochemical aspect have been performed using the blood samples of the Phensedyl abusers of Gaibandha District, in the Northern region of Bangladesh were the abuse of Phensedyl is reportedly to be very high (Two held with Phensedyl in Gaibandha, The Daily Sun 2010).
Materials and Methods
The study population consisted of 127 male Phensedyl addicts within the ages of 18-55 years of defined criteria (Male individuals who only took Phensedyl, not multi drug users, belonging to the age group of 18-55 yrs and having no evidence of coronary heart disease (CHD), stroke or other major illnesses) from Gaibandha district, a northern part of Bangladesh, during the period of July 2007 to December 2009. Fifty (50) non-drug dependent (non-users of any tobacco, betel leaves or nuts) healthy men who were similar in age, height, and socioeconomic status were recruited by convenience as controls from the same community. To conduct the study ethical permission was sought from the Director, Institute of Biological Sciences, University of Rajshahi, Bangladesh. The study subjects were briefed about the objective of the study and a written consent was obtained from each of them. Then blood specimens (10 ml) were collected from each of the subjects by venipuncture, which were used as research tool. Biochemical parameters analyzed includeSerum creatinine, SGOT, SGPT and Lipid profiles (total serum cholesterol (TC), Serum triglyceride (TG), serum high-density lipoprotein (HDL) and low-density lipoprotein (LDL) cholesterol.
Estimation of serum creatinine was done by Creatinine liquicolor kit (Human, Germany) by Jaffe -Reaction, Serum cholesterol by enzymatic -colorimetric (CHOD -PAP) method using Cholesterol (Spinreact SA, Spain) kit on TC 84 chemistry Analyzer (Teco Diagnostics, USA) at 505 nm. Serum Triglyceride was determined by enzymatic-colometric GPO -PAP method using Triglyceride GPO liquicolor (Human -GMBH, Germany) kit, Serum HDL cholesterol by phosphotungstate / magnesium method (Burstein et al., 1970) using HDL cholesterol (Spinreact SA, Spain) kit. LDL-Cholesterol was calculated from the estimated serum triglycerides, Total Cholesterol (TC) and HDL-Cholesterol by using the Friedwald's formula (Friedewald et al.1972) . Statistical data analysis of was performed using SPSS windows version.
Results
This study has investigated one hundred twenty seven (127) male Phensedyl addicts of within the ages of 18-45 years. Their serum blood were analyzed for some biochemical parameters of clinical importance and was compared with non-drug dependent control subjects.
Serum creatinine levels:
To observe the effect of Phensedyl abuse on kidney function of the abusers, serum creatinine level of the addicts were determined and the results have been presented in Table 1 . The results clearly indicated that no major changes in serum creatinine concentration occurred as a result of Phensedyl intake in addicts of all age groups and remained within the normal values (0.6-2.0 mg/dl). 
SGOT and SGPT levels:
The SGOT activity of the Phensedyl addicts was measured to monitor for hepatic damages. The data gave evidence of no significant hepatic changes as the SGOT activity remained within the normal value in those who had been (44%, n = 56) taking CCS (Phensedyl) for less than 8 years. Similarly, SGOT levels of the abusers (56%, n=71) who took the drug for more than 8 years also had normal values (Table 2 ). It was also observed that the serum SGOT level of the addicts remained within the normal range irrespective of the age group and the results have been presented in Table 3 . SGPT or ALT is an enzyme present in higher concentration in liver than in muscle. Consequently an elevation is more specific for liver disease. The results of determination of serum SGPT activity of the present study has been presented in Table 4 . The results suggested that codeine containing cough syrup had very little effect on the serum SGPT level of the Phensedyl abusers, as no significant changes in serum SGPT concentration was noticed. The number of individuals belonging to age group of 20 -25 years was 12 (9.44%). Fourteen (14) of the abusers (11.02%, age above 35 years) had the normal value of serum SGPT level (Table 4) . However, 3.14% (n = 4) of the abusers belonging to the age group of 26 -35 year had raised level of serum SGPT. On the other hand 76.37% (n=97) of abusers had normal value of same age group.
Serum Total cholesterol (TC) level:
Serum TC of the addicts and non-addict controls are presented in Table 5 . Results showed that TC level in the Phensedyl addict's sera was not significantly changed as a result of Phensedyl abuse. Serum TC levels in the drug addicts ranged within 100 and 240 mg/dl, while in the non-addict controls it was within 200 mg/dl. But very interestingly, higher trends in the serum TC were observed in most of the phensedyl abusers and they had levels more than 200 mg/dl and abusing the drug for more than 8 years.
Serum Triglyceride (TG) level:
Serum TG levels of the addicts and control subjects are presented in the Table  6 . TG levels of addicts were significantly higher than the non-addict controls and the changes in serum TG values were found to be time-dependant. Out of total 127 addicts, 44.34% (n=56) taking Phensedyl for less than 8 years had serum TG levels within the normal range (upto150 mg/dl). Among the addicts, 45.66% (n = 58) were recorded to have raised triglyceride values that appeared to be clinically very significant. The raised serum TG concentration observed in n=56 abusers who had been abusing Phensedyl for more than eight years was found to be statistically highly significant (shown in Anova table for Triglyceride, below Table 6 ).
In 10% of the addicts, who had abused Phensedyl for more than 8 year had normal serum triglyceride levels. ANOVA for triglyceride was calculated to be between groups SS value was 164037.6559, df was 1, MS was 164037.6559, F was 115.59 and P value was 0.0001 (ANOVA Table for triglyceride, below Table 6 ). In Pvalue interpretation values less than 0.01 is considered statistically very significant. In case of less than 8 years of abuse, the SD was 14.44, CV was 13.54 and the t-value was 2.98. For more than 8 years, the SD and CV were 48.69, 27.20 and t-value was 9.82, which was more significant at 1% level (Table 8) . Tables 7-8 serum HDL levels of the addicts was significantly lower than the nonaddict controls. Of the addicts 53.53% had low level of HDL out of which 43.30% were taking Phensedyl for more than 8 years. Among the addicts, 46.38% were recorded to have normal value out of which 33% took the drug for less than 8 years. Lowering in HDL level noticed among addicts is clinically very significant and indicated that they might have developed various types of heart diseases. The decreased serum level of HDL was also found to be statistically highly significant in Analysis of variance (ANOVA for HDL, below Table 7 ). In P-value interpretation values less than 0.01 is considered statistically very significant. In our analysis between groups, the calculated p-value was 0.002. Also the calculated t-value for more than 8 years of addiction was 12.69 (Table 8) , which is significant at 1% level, i.e. decrease in the HDL (good cholesterol) level than the normal value. Therefore, the reductions in HDL level were statistically very significant. 
LDL levels
Serum LDL cholesterol level of the addicts are presented in the Tables 8 and 9 . Out of the total participants (127), 43.30% (n = 55) who abused phensedyl for less than 8 years had LDL values within the normal ranges. 72 addicts' took Phensedyl (CCS) for more than 8 years and of them 43 addicts (34%) had raised LDL cholesterol level which was clinically significant while the rest addicts had normal serum LDL levels.
In analysis of variance (ANOVA), the SS, df, MS, F and P-value between groups respectively were 36481.5232, 1, 36481.5232, 59.00 and 0.0001. In P-value interpretation values less than 0.01 is considered as statistically very significant (shown below Table 9 ). As shown in Table 8 , the mean of addiction period less than 8 years were 114.39 and more than 8 years were 148.60. The SD in less than 8 years of intake was 16.38, whereas, more than 8 years of intake of Phensedyl was 29.74. The calculated t-value in below 8 years addict groups was 0.84 and found to be statistically non-significant. But the t-value calculated in case of addicts taking phensedyl above 8 years was 29.88, which was significant at 1% level. The above statistical analyses indicated that the elevation in serum LDL cholesterol concentrations in phensedyl abusers were highly significant.
Discussion
In the present study, the serum creatinine levels of Phensedyl addicts remained unchanged even after long time abuse (8 years or more) of the drug. So, abuse of Phensedyl appears to have no major effect on renal function of the addicts. This finding of ours is similar to that reported by IPCS (International Program on chemical Safety) that codeine, promethazine and phenylephrine -the ingredients of Phensedyl syrup cause no major changes in renal function but may cause minor urinary retention in some people. But Jaffe and Kimmel (2006) in their recent critical review on Chronic Nephropathies of Cocaine and Heroin abuse mentioned that renal disease in cocaine and heroin abusers (in injectable form) has been associated with the nephrotic syndrome, acute glomerulonephritis, amyloidosis, interstitial nephritis, and rhabdomyolysis. As Phensedyl syrup is taken only by oral route while cocaine and heroin can be taken in different forms.
To evaluate the toxicity of Phensedyl on liver, SGOT and SGPT levels were measured from blood samples of the addicts. The SGOT and SGPT levels of the addicts remained within the normal values irrespective of age and drug abuse period of less or more than 8 years suggesting that Phensedyl abuse did not alter the liver function of the addicts.
Our such finding disagree with the findings of Balasubramaniam et al. (1994) working on Biochemical changes in Heroin (which is also an opiate as one of the ingredients of Phensedyl syrup) addicts reported SGOT and SGPT levels of heroin addicts (opiates) were significantly higher than in the non-addicts. Liver damage due to hepatitis is also reported by Abelson (1970) when heroin is regularly taken a few times a day in small doses.
The results of lipid profile of the current study showed higher trends in the serum Total Cholesterol (TC) (>200 mg/dl), significantly elevated TG, raised LDL Cholesterol levels and significantly lower level of HDL Cholesterol levels in most of the Phensedyl (CCS) abusers abusing the drug for more than 8 years as compared to the non-addicts. The result suggests that Phensedyl alters the lipid profile causing dyslipidaemia after eight years of continuous intake of the drug i.e. the change in the lipid profile is time dependent.
The above finding of ours agrees very well with the study of Mohammadi et al. (2009) that opium use can increase serum levels of lipids that ends up as atheroma formation in the aorta of addicted rats. They also found out an association between the duration of addiction and increase in serum level of lipids, a risk factor, for cardiovascular diseases. Asgary et al. [18] showed that there was a direct correlation between opioids blood levels and duration of addiction. In their study, they also noted that the levels of Fibrinogen, apo B (Elevated levels of apo B correspond to elevated levels of LDL-C,) Lpa, were significantly higher in the case subjects as compared with controls, and that HDL-cholesterol and apo-a were significantly lower in the case subjects, That would mean that opium acts as a cardiovascular disease risk factor. Balasubramanium et al. (1994) working on Biochemical changes in Heroin (which is also an opiate drug like Phensedyl syrup) addicts that reported total serum, cholesterol to be significantly higher than the non addicts.
According to American Heart association cholesterol concentration more than 200 mg/dl raises the risk of stroke, coronary heart disease, ischemic stroke etc. Therefore, the Phensedyl abusers are at the risk of developing the above diseases.
A high level of HDL is an indication of a healthy metabolic system if there is no sign of liver disease or intoxication. HDL is called the "good cholesterol" because HDL cholesterol particles prevent atherosclerosis by extracting cholesterol from the artery walls and disposing of them through the liver. Thus, high levels of LDL cholesterol and low levels of HDL cholesterol (high LDL/HDL ratios) are risk factors for atherosclerosis, while low levels of LDL cholesterol and high level of HDL cholesterol (low LDL/HDL ratios) are desirable.
The decrease in the HDL level in the addicts is clinically significant. According to American Heart association low levels of serum HDL are associated with an increased incidence of CHD and increased mortality rate. At the other extreme, individuals with high concentrations of HDL, as in familial hyperalphalipoproteinaemia seldom present with symptoms of CHD indicating a protective role of high concentrations of HDL against atherogenicity and development of CHD. LDL cholesterol is called "bad" cholesterol, as elevated LDL cholesterol is associated with an increased risk of coronary heart disease. LDL lipoprotein deposits cholesterol on the artery walls causing atherosclerosis. Lack of oxygen (ischemia) to the heart muscle causes chest pain, also formation of a blood clot in the artery can clause complete blockage of the artery, leading to death of heart muscle (heart attack). The results indicated that the Phensedyl abusers are at the risk of developing various types of heart diseases.
In conclusion, the results of the present study indicated that the Phensedyl abusers might develop various types of heart diseases like MI, Coronary Heart Disease CHD and TIA etc as there is the triad of: Elevated LDL cholesterol, Low HDL cholesterol and elevated Triglyceride.
